Wróblewski, H. and Zimna, A. 2021. Use of Rifaximin in Irritable Bowel Syndrome Treatment. Journal of Education, Health and Sport. 11, 8 (Aug. 2021), 247–254. DOI:https://doi.org/10.12775/JEHS.2021.11.08.025.